35
Views
23
CrossRef citations to date
0
Altmetric
Review

Renal angioplasty and stenting: long-term results and the potential role of protection devices

, , , , &
Pages 321-334 | Published online: 10 Jan 2014

References

  • Rihal CS, Textor SC, Breen JF et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin. Proc. 77, 309–316 (2002).
  • Missouris CG, Buckenham T, Cappucio FP et al. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am. J. Med. 96, 10–14 (1994).
  • Gross CM, Krämer J, Waigland J et al. Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cath. Cardiovasc. Diagn. 45, 1–8 (1998).
  • Jean WJ, al-Bitar I, Zwicke DL et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cath. Cardiovasc. Diagn. 32, 8–10 (1994).
  • Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Uro. Clin. North Am. 11, 383–392 (1984).
  • Strandness DE Jr. Natural history of renal artery stenosis. Am. J. Kidney Dis. 24, 630–635 (1994).
  • Zierler RE. Screening for renal artery stenosis: is it justified. Mayo Clin. Proc. 77, 307–308 (2002).
  • Subramanyan R, Joy J, Balakrishnan KG. Natural History of Aortoarteritis (Takayasu’s disease). Circulation 80, 429–437 (1989).
  • Sharma S, Jain AK. Natural history of nonspecific aortoarteritis. In: Nonspecific Aorto Arteritis. Manotosh Panja (Ed.). Marksman Media Services Kolkata, India (2001).
  • Goncharenko V, Gerlock AJ, Schaff MI et al. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology 139, 45–50 (1981).
  • Knutson DW, Abt AB. Pathophysiology, pathology and clinical features of renovascular hypertension In: Vascular Diseases. Strandness E, Arena Van Breda A (Eds). Churchill Livingstone, Inc. NY, USA, 673 (1994).
  • Berglund G, Anderson O, Wilhelmsen L. Prevalence of primary and secondary hypertension studies in a random population sample. Br. Med. J. 2, 554–556 (1976).
  • Pickering TG. Renovascular hypertension: medical evaluation and nonsurgical treatment. In: Hypertension: Physiopathology, Diagnosis and Mangement. Laragh JM, Brenner BM (Eds). Raven Press, NY, USA, 1539 (1990).
  • Messena LM, Zelenock GB, Yaok A et al. Renal vascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with atherosclerotic renal artery occlusive disease. J. Vasc. Surg. 20, 76–87 (1994).
  • Stane Y, Gyepes MT, Olson DL et al. Renovascular hypertension in children and adolescents. Radiology 129, 123–128 (1978).
  • Sos TA, Pickering TG, Sniderman K et al. Percutaneous transluminal angioplasty in renovascular hypertnesion due to atheroma or fibromuscular hyperplasia. N. Engl. J. Med. 309, 274–278 (1983).
  • Novick AC. Ziegelbaum M, Vidt DG et al. Trends in surgical revascularization for renal artery disease: 10 years’ experience. J. Am. Med. Assoc. 257, 498–501 (1987).
  • Weibull H, Bergqvist D, Bergentz SE et al. PTRA versus surgical reconstruction of atherosclerotic renal stenosis: a prospective randomized study. J. Vasc. Surg. 18, 841–852 (1993).
  • Cambria RP. Surgery: indications and variables that affect procedural outcome, as well as morbidity and mortality. J. Invas. Card. 10, 55–58 (1998).
  • Van de Ven PJ, Kaatee R, Beutler JJ et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomized trial. Lancet 353, 282–286 (1999).
  • Henry M, Amor M, Henry I et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J. Endovasc. Surg. 6, 42–51 (1999).
  • Henry M, Amor M, Henry I et al. Stent placement in the renal artery: 3-year experience with the Palmaz stent. J. Vasc. Interv. Radiol. 7, 343–350 (1996).
  • Blum U, Krumme B, Flugel P et al. Treatment of ostial renal artery stenosis with vascular endoprostheses after unsuccessful balloon angioplasty. N. Engl. J. Med. 336, 459–465 (1997).
  • Van de Ven PJ, Beutler JJ, Kaatee R et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 346, 672–674 (1995).
  • Dorros G, Jaff M, Jain A et al. Follow-up of primary Palmaz–Schatz stent placement for atherosclerotic renal artery stenosis. Am. J. Cardiol. 75, 1051–1055 (1995).
  • Zeller TH. Endovascular treatment of renal artery stenosis: technical aspects. Long-term clinical results and restenosis rate. In: Paris Course Revascularization Book. Marco J, Biamino G (Eds). 333–364 (2000).
  • Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized, controlled trials. Am. J. Med. 114, 44–50 (2003).
  • Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. Br. Med. J. 300, 569–572 (1930).
  • O’Donovan RM, Gutierrez OH, Izzo JL. Preservation of renal function by percutaneous renal angioplasty in high-risk elderly patients: short-term outcome. Nephron 60, 187–192 (1992).
  • Pattison JM, Reidy JF, Rafferty MJ et al. Percutaneous transluminal renal angioplasty in patients with renal failure. QJ Med. 85, 883–888 (1992).
  • Taylor A, Sheppard D, MacLeod MJ et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin. Radiol. 52, 451–457 (1997).
  • Harden PN, MacLeod MJ, Rodger RS et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 349, 1133–1136 (1997).
  • Iannone LA, Underwood P, Nath A et al. Effect of primary balloon expandable renal artery stents on long-term patency, renal function and balloon pressure in hypertension and renal insufficient patients with renal artery stenosis. Cathet. Cardiovasc. Diagn. 37, 243–250 (1996).
  • Dorros G, Jaff M, Mathiak L et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: 4-year follow-up of 1058 successful patients. Cathet. Cardiovasc. Interv. 55, 182–188 (2002).
  • Fiala LA, Jackson MR, Gillespie DL et al. Primary stenting of atherosclerotic renal artery ostial stenosis. Ann. Vasc. Surg. 12, 128–133 (1998).
  • Plouin PF, Chatellier G, Darne B et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs. Angioplastie (EMMA) Study group. Hypertension 31, 823–829 (1998).
  • White CJ, Ramee SR, Collins TJ et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J. Am. Coll. Cardiol. 30, 1445–1450 (1997).
  • Dorros G, Jaff M, Mathiak L et al. 4-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 98, 642–647 (1998).
  • Zeller T, Frank U, Muller C et al. Stent supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control. J. Endovasc. Ther. 11, 95–106 (2004).
  • Rocha Sing KJ, Miskkel GJ, Kathodi RE et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Cathet. Cardiovasc. Intervent. 47, 167–172 (1999).
  • Von Knorring J, Edgren J, Lepantalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiol. 37, 36–40 (1996).
  • Paulsen D, Klow NE, Rogstad B et al. Preservation of renal function by percutaneous transluminal angioplasty in ischemic renal disease. Nephrol. Dial. Transplant. 14, 1454–1461 (1999).
  • Rodriguez-Lopez JA, Werner A, Ray LI et al. Renal artery stenosis treated with stent deployment: indications, technique, and outcome in 108 patients. J. Vasc. Surg. 29, 617–624 (1999).
  • Watson P, Madjipetrou P, Cox S et al. Effects of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 102, 1671–1677 (2000).
  • Subramanian R, Silva JA, Ramee SR et al. Beneficial effects of chronic renal insufficiency. Eur. Heart J. P577, 97 (2002).
  • Guerrero, Kunjmmen B, Khaleel R et al. Stabilization of renal function after renal artery stenting. Am. J. Cardiol. 90, 63H (2002).
  • Henry M, Klonaris C, Henry I. Renal stenting with the Percusurge Guardwire device: a pilot study. J. Endovasc. Ther. 8, 227–237 (2001).
  • Henry M, Henry I, Klonaris C et al. Renal angioplasty and stenting under protection. The way for the future? Cath. Cardiovasc. Interv. 60, 299–312 (2003).
  • Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJ Med. 92, 159–167 (1999).
  • Boisclair C, Therasse E, Olivia VL et al. Treatment of renal angioplasty failure by perculaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. Am. J. Roentgenol. 168, 245–251 (1997).
  • Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101, 570–580 (2000).
  • Baim DS, Wahr D, George B et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105, 1285–1290 (2002).
  • Limbruno U, Micheli A, De Carlo M et al. Mechanical protection of distal embolization during primary angioplasty: safety, feasability, and impact on myocardial reperfusion. Circulation 108, 171–176 (2003).
  • Ohki T, Marin ML, Lyon RT et al. Ex vivo human carotid artery bifurcation stenting: correlation of lesion characteristics with embolic potential. J. Vasc. Surg. 27, 463–471 (1998).
  • Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experimence. J. Vasc. Surg. 38, 962–968 (2003).
  • Walker C, Kowalski J, Knan M et al. Proximal protection before distal protection: preventing large atheroemboly during renal intervention. Am. J. Cardiol. 90, 28H (2002).
  • Henry M, Henry I, Klonaris C et al. Benefits of cerebral protection during carotid stenting with the Percursurge Guardwire system: midterm results. J. Endovasc. Ther. 9, 1–13 (2002).
  • Reimers B, Corvaja N, Moshiris A et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 104, 12–15 (2001).
  • Roubin GS. Carotid angioplasty and stenting under cerebral protection: the standard of care. International Congress XV. Scottsdale, AZ, USA, 11–14 February 2002.
  • Eggebrecht H, Haude M, Baumgart D et al. A new temporary occlusion and aspiration system prevention of distal embolization during percutaneous transluminal renal angioplasty. J. Intervent. Cardiol. 13, 339–342 (2000).
  • Li SS, Wang CH, Lam CW. Renal angioplasty under protection of the Percusurge Guardwire Plus system. J. Invas. Cardiol. 15, 148–150 (2003).
  • Guerkens U, Mueller R, Soblik S et al. A new protection device to prevent distal embolization in peripheral interventions. First results in renal and carotid arteries. American College Cardiology Meeting. Anaheim, Germany, 12–15 March 2000.
  • Commeau P, Barragan P, Huret B et al. Direct stenting in the treatment of renal artery stenosis: immediate and in-hospital results. Am. J. Cardiol. Transcath. Cardiovasc. Ther. 74 (2001).
  • Morice MC, Marco J, Laborde JC et al. The French registry on renal stenting. Am. J. Cardiol. 90, 67H (2002).
  • Thadani RI, Camargo CAJr, Xavier RJ et al. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine (Baltimore) 74, 350–358 (1995).
  • Haqqie SS, Urizar RE, Singh J. Nephrotic-range proteinuria in renal atheroembolic disease: report of four cases. Am. J. Kidney Dis. 28, 493–501 (1996).
  • Krishnamurthi V, Novick AC, Myles JL. Atheroembolic renal disease: effect on morbidity and survival after renovascularization for atherosclerotic renal artery stenting. Cathet. Cardiovasc. Interv. 46, 245–248 (1999).
  • Boero R, Borcam M, Ladarola GM et al. Acute Kidney failure caused by cholesterol embolism. Minerva Urol. Nefrol. 52, 119–122 (2000).
  • Sos T, Trost D. The importance of renal stenting in ischemic nephropathy. Endovasc.Today 2, 44–46 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.